Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 06:30PM GMT
Release Date Price: $56.14 (+4.58%)
Max Masucci
Cowen and Company, LLC, Research Division - Senior Analyst

Hi, everybody. Thank you for being here. I'm Max Masucci from Cowen's Life Science Diagnostic Tools Research team. We are pleased to be joined by Guardant Health, the liquid biopsy market leader and a key player across blood-based applications for therapy selection, MRD monitoring and noninvasive screening.

We're joined today by co-CEO, AmirAli Talasaz; and CFO, Mike Bell. Gentlemen, thanks for being here.

AmirAli Talasaz
Guardant Health, Inc. - Co-CEO & Director

Yes, thanks you for having us.

Questions & Answers

Max Masucci
Cowen and Company, LLC, Research Division - Senior Analyst

Great. All right. So let's start right in. We had an MRD monitoring panel yesterday morning. We had a screening panel in the afternoon. I'm not going to ask you to predict the final sensitivity number in the ECLIPSE trial. But if we take into consideration a few things. Number 1, the quality and availability of biobank samples you used in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot